Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) has issued an update.
Ind-Swift Laboratories Ltd. has informed the stock exchanges that 232,057 equity shares, originally held by the late promoter shareholder Neera Mehta, have now been transmitted to the joint demat account of her three legal heirs, all of whom are part of the company’s promoter and promoter group. The transfer, completed following regulatory approvals linked to the earlier amalgamation of Ind-Swift Limited with Ind-Swift Laboratories Limited and undertaken under an exemption for inter-se promoter transfers in the SEBI takeover regulations, results in no change to the aggregate shareholding of the promoters, signalling a purely intra-family realignment of ownership with no immediate implications for control or public shareholders.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. is an India-listed pharmaceutical company whose equity shares trade on both BSE and the National Stock Exchange of India. The company operates in the pharma and life sciences sector, with its shareholder base including a defined promoter and promoter group that actively manage and hold a significant stake in the business.
Average Trading Volume: 5,441
Technical Sentiment Signal: Hold
Current Market Cap: 7.77B INR
Find detailed analytics on INDSWFTLAB stock on TipRanks’ Stock Analysis page.